Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Sampling Plans01:23

Sampling Plans

Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Approach to Manage Hypercholesterolemia: Veterans Affairs Lipid Optimization Reimagined Quality Improvement Program.

JACC. Advances·2026
Same author

Autism-ness Does Not Exist, but Autism Does, Part 2: The Perception-Language Chimera Model Accounts for the Nature, Chronology, and Interrelation of Autistic Signs.

Autism & developmental language impairments·2026
Same author

Mycobacterium tuberculosis transmission from tuberculosis patients with and without recognized symptoms: a case-contact study in eastern China.

Nature communications·2026
Same author

Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis.

AIDS (London, England)·2026
Same author

Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission.

The Lancet. Infectious diseases·2026
Same author

Cost-Effectiveness of Community Tuberculosis Screening in South Africa.

American journal of respiratory and critical care medicine·2026
Same journal

Integrating health economics and implementation science: a call to action.

BMC medical research methodology·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Evaluation of exposure-specific risks from two independent samples: a simulation study.

William M Reichmann1, David Gagnon, C Robert Horsburgh

  • 1Department of Orthopedic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. wreichmann@partners.org

BMC Medical Research Methodology
|January 7, 2011
PubMed
Summary
This summary is machine-generated.

A revised product-based estimator significantly improves accuracy for calculating exposure-specific risks (ESR), outperforming the current simple method, especially in complex scenarios. This new approach offers more reliable confidence intervals for epidemiological studies.

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Related Experiment Videos

Last Updated: Jun 5, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Area of Science:

  • Epidemiology
  • Biostatistics
  • Public Health Research

Background:

  • Existing simple product-based estimators for exposure-specific risks (ESR) lack rigorous evaluation.
  • A need exists for improved methodologies to accurately calculate ESR and associated confidence intervals (CIs).

Purpose of the Study:

  • To rigorously evaluate the current simple product-based estimator for ESR.
  • To propose a revised product-based point estimator for improved accuracy.
  • To develop variance estimates for calculating reliable confidence intervals for ESR.

Main Methods:

  • A simulation study compared the current simple product-based estimator with a proposed revised product-based estimator.
  • Estimators were evaluated based on relative bias (accuracy) and confidence interval performance (coverage probability, expected length).
  • Log-based and binomial-based variances were calculated for confidence interval estimation.

Main Results:

  • The current simple product-based estimator exhibited substantial bias (up to 93.9%) and low CI coverage.
  • The revised product-based estimator demonstrated significantly less bias (max 4.0%) and better CI coverage.
  • Log-based variance provided improved CI coverage for the revised estimator in most simulated scenarios.

Conclusions:

  • The simple product-based method is only reliable for low exposure probabilities (< 0.05) and relative risks (RR) ≤ 3.0.
  • The revised product-based estimator offers substantially improved accuracy and reliability for ESR calculations.
  • The proposed methodology enhances the precision of risk estimation in epidemiological research.